Tristel PLC
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TSNLF research report →
Companytristel.com
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
- CEO
- Matthew Giovanni Sassone
- IPO
- 2014
- Employees
- 233
- HQ
- Snailwell, GB
Price Chart
Valuation
- Market Cap
- $265.36M
- P/E
- 23.07
- P/S
- 3.68
- P/B
- 5.41
- EV/EBITDA
- 14.46
- Div Yield
- 3.74%
Profitability
- Gross Margin
- 78.65%
- Op Margin
- 19.72%
- Net Margin
- 15.88%
- ROE
- 23.64%
- ROIC
- 19.70%
Growth & Income
- Revenue
- $46.46M · 10.80%
- Net Income
- $6.64M · 2.33%
- EPS
- $0.14 · 0.00%
- Op Income
- $8.40M
- FCF YoY
- 8.67%
Performance & Tape
- 52W High
- $6.00
- 52W Low
- $5.00
- 50D MA
- $5.40
- 200D MA
- $5.38
- Beta
- 0.34
- Avg Volume
- 70
Get TickerSpark's AI analysis on TSNLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TSNLF Coverage
We haven't published any research on TSNLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TSNLF Report →